Scott Lewis, DO
Rheumatology · Somerset, KYNPI 1336368505
Payments from drug & device makers
Across 1,296 payments — averaging $54.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eli Lilly$29K
- Novartis$24K
- AbbVie$3K
- Amgen$3K
- Johnson & Johnson$2K
- Pfizer$2K
- plus $8K from 27 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eli Lilly | 1 | $28,999 |
| Novartis | 121 | $23,783 |
| AbbVie | 209 | $3,376 |
| Amgen(2 entities) | 237 | $3,044 |
| Johnson & Johnson(2 entities) | 106 | $1,903 |
| Pfizer | 140 | $1,577 |
| AstraZeneca(2 entities) | 65 | $1,361 |
| UCB, Inc. | 89 | $1,277 |
| E.r. Squibb & Sons, L.L.C. | 83 | $1,204 |
| GSK | 56 | $921 |
| Lilly USA, LLC | 46 | $480 |
| Mallinckrodt Hospital Products Inc. | 12 | $283 |
| Aurinia Pharma U.S., Inc. | 20 | $234 |
| Boehringer Ingelheim | 11 | $216 |
| Pacira Therapeutics, Inc. | 15 | $197 |
| Radius Health, Inc. | 11 | $184 |
| Sobi, Inc | 9 | $152 |
| Bristol Myers Squibb | 18 | $140 |
| Sanofi | 4 | $133 |
| ANI Pharmaceuticals, Inc. | 6 | $119 |
| Regeneron Healthcare Solutions, Inc. | 7 | $119 |
| Organon | 6 | $94 |
| Fresenius Kabi USA, LLC | 5 | $79 |
| Sandoz | 4 | $71 |
| Mallinckrodt Enterprises LLC | 3 | $66 |
| Genentech USA, Inc. | 4 | $60 |
| Tersera Therapeutics LLC | 2 | $53 |
| Globus Medical | 1 | $44 |
| Kyowa Kirin, Inc. | 1 | $23 |
| Almatica Pharma LLC | 1 | $19 |
| Actelion Pharmaceuticals US, Inc. | 1 | $18 |
| Orthogenrx Inc. | 1 | $14 |
| Ascend Therapeutics US, LLC | 1 | $12 |
How this compares
$70,255 in reported general payments places this provider in the 85th percentile of 81 rheumatology providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other rheumatology in Somerset
- Timothy LoneskySomerset$328K
- Jeffrey NealLexington$1.8M
- Kishorkumar DesaiHopkinsville$1.3M
- Asad FraserBowling Green$707K
- Alexander BrownLexington$614K
- Housam SarakbiLouisville$297K
- Paramarajan PiranavanLexington$283K
- Rebecca CallisFlorence$272K
- Daksha MehtaElizabethtown$234K
- Gary CrumpLouisville$176K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.